Bright Health Group, Inc. (NYSE:BHG – Get Rating) has received an average recommendation of “Hold” from the ten research firms that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $2.46.
Several analysts recently weighed in on the company. Citigroup decreased their price target on Bright Health Group from $2.25 to $1.20 and set a “neutral” rating on the stock in a report on Wednesday, November 16th. JPMorgan Chase & Co. downgraded Bright Health Group from a “neutral” rating to an “underweight” rating in a research report on Tuesday, October 11th. The Goldman Sachs Group downgraded Bright Health Group from a “neutral” rating to a “sell” rating in a research report on Tuesday, December 13th. Finally, Cowen cut their price objective on Bright Health Group to $1.00 in a research report on Wednesday, November 16th.
Insider Transactions at Bright Health Group
In other news, Director Jeffrey R. Immelt purchased 400,000 shares of the company’s stock in a transaction dated Wednesday, December 14th. The shares were acquired at an average price of $0.62 per share, with a total value of $248,000.00. Following the transaction, the director now owns 598,012 shares of the company’s stock, valued at $370,767.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, Director Jeffrey R. Immelt purchased 400,000 shares of the company’s stock in a transaction dated Wednesday, December 14th. The shares were acquired at an average price of $0.62 per share, with a total value of $248,000.00. Following the transaction, the director now owns 598,012 shares of the company’s stock, valued at $370,767.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Manuel Kadre acquired 303,307 shares of the firm’s stock in a transaction that occurred on Monday, November 14th. The shares were bought at an average price of $0.96 per share, with a total value of $291,174.72. Following the completion of the purchase, the director now directly owns 885,112 shares in the company, valued at $849,707.52. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 767,794 shares of company stock valued at $605,596. 49.80% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Bright Health Group
Hedge funds have recently made changes to their positions in the stock. Dixon Hubard Feinour & Brown Inc. VA purchased a new stake in shares of Bright Health Group during the 2nd quarter worth $27,000. Evoke Wealth LLC purchased a new stake in shares of Bright Health Group during the 2nd quarter worth $1,532,000. Private Advisor Group LLC purchased a new stake in shares of Bright Health Group during the 2nd quarter worth $27,000. G&S Capital LLC purchased a new stake in shares of Bright Health Group during the 2nd quarter worth $25,000. Finally, Red Door Wealth Management LLC purchased a new stake in shares of Bright Health Group during the 2nd quarter worth $72,000.
Bright Health Group Stock Performance
NYSE:BHG opened at $0.58 on Friday. The stock’s fifty day moving average is $0.81 and its 200 day moving average is $1.29. Bright Health Group has a fifty-two week low of $0.49 and a fifty-two week high of $4.06. The firm has a market capitalization of $367.74 million, a PE ratio of -0.23 and a beta of 0.39.
Bright Health Group (NYSE:BHG – Get Rating) last released its quarterly earnings results on Wednesday, November 9th. The company reported ($0.35) earnings per share for the quarter, beating the consensus estimate of ($0.40) by $0.05. Bright Health Group had a negative return on equity of 190.07% and a negative net margin of 26.48%. The company had revenue of $1.63 billion for the quarter, compared to analyst estimates of $1.78 billion. Equities analysts forecast that Bright Health Group will post -1.64 EPS for the current year.
Bright Health Group Company Profile
Bright Health Group, Inc, a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bright Health Group, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Bright Health Group wasn’t on the list.
While Bright Health Group currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: news.google.com
